APLD vs REGN · rev $144.2M vs P/E 14, rev $14.34B
Applied Digital Corporation (APLD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Applied Digital Corporation (APLD) is a information technology services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported APLD revenue for 2025-05-31 was $144.2M. Net income was -$231.1M. Revenue was up 5.5% from 2024-05-31 to 2025-05-31. APLD currently screens at market cap $2.10B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
APLD currently screens at market cap $2.10B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the APLD and REGN stock pages for the full models.
Not investment advice.